The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1067159021 10671590 21 F 20130906 20160701 20141223 20160707 EXP US-GLAXOSMITHKLINE-US2014GSK040252 GLAXOSMITHKLINE 62.33 YR F Y 112.93000 KG 20160707 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1067159021 10671590 1 PS FLOLAN EPOPROSTENOL SODIUM 1 UNK U R113 20444 POWDER FOR INFUSION
1067159021 10671590 2 SS FLOLAN EPOPROSTENOL SODIUM 1 11 NG/KG/MIN U T366 20444 POWDER FOR INFUSION
1067159021 10671590 3 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 11 NG/KG/MIN CONTINUOUS; CONCENTRATION: 30,000 NG/ML; PUMP RATE: 61 ML/DAY; VIAL STRENGTH: 1.5 MG,CO U T662 20444 POWDER FOR INFUSION
1067159021 10671590 4 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 17 NG/KG/MIN CONTINUOUS; CONCENTRATION: 45,000 NG/ML; PUMP RATE: 63 ML/DAY; VIAL STRENGTH: 1.5 MG,CO U T794 20444 POWDER FOR INFUSION
1067159021 10671590 5 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK, CO U T856 20444 POWDER FOR INFUSION
1067159021 10671590 6 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 21 NG/KG/MIN U T856 20444 POWDER FOR INFUSION
1067159021 10671590 7 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK, CO U U631 20444 POWDER FOR INFUSION
1067159021 10671590 8 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U 20444 POWDER FOR INFUSION
1067159021 10671590 9 SS FLOLAN EPOPROSTENOL SODIUM 1 30 NG/KG/MIN, CO U U631 20444 POWDER FOR INFUSION
1067159021 10671590 10 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK, CO U V049 20444 POWDER FOR INFUSION
1067159021 10671590 11 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK, CO U V378 20444 POWDER FOR INFUSION
1067159021 10671590 12 SS FLOLAN EPOPROSTENOL SODIUM 1 36 DF, CO U V785 20444 36 DF POWDER FOR INFUSION
1067159021 10671590 13 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) UNK, CO U Z111 20444 POWDER FOR INFUSION
1067159021 10671590 14 SS FLOLAN EPOPROSTENOL SODIUM 1 36 NG/KG/MIN (CONCENTRATION 75,000 NG/ML, PUMP RATE 80 ML/DAY, VIAL STRENGTH 1.5 MG), CO U Z606 20444 POWDER FOR INFUSION
1067159021 10671590 15 SS ADEMPAS RIOCIGUAT 1 0.5 MG, TID Y 0 .5 MG TID
1067159021 10671590 16 SS ADEMPAS RIOCIGUAT 1 0.5 MG, QD Y 0 .5 MG QD
1067159021 10671590 17 SS ADEMPAS RIOCIGUAT 1 0.5 MG, BID Y 0 .5 MG BID
1067159021 10671590 18 C REVATIO SILDENAFIL CITRATE 1 U 0
1067159021 10671590 19 C NORVASC AMLODIPINE BESYLATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1067159021 10671590 1 Pulmonary arterial hypertension
1067159021 10671590 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
1067159021 10671590 HO
1067159021 10671590 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1067159021 10671590 Adverse event
1067159021 10671590 Blister
1067159021 10671590 Blood pressure increased
1067159021 10671590 Catheter site discharge
1067159021 10671590 Catheter site erythema
1067159021 10671590 Catheter site extravasation
1067159021 10671590 Catheter site haemorrhage
1067159021 10671590 Catheter site pain
1067159021 10671590 Central venous catheter removal
1067159021 10671590 Central venous catheterisation
1067159021 10671590 Chest discomfort
1067159021 10671590 Choking sensation
1067159021 10671590 Complication associated with device
1067159021 10671590 Cough
1067159021 10671590 Dermatitis contact
1067159021 10671590 Device breakage
1067159021 10671590 Device leakage
1067159021 10671590 Device malfunction
1067159021 10671590 Diarrhoea
1067159021 10671590 Dizziness
1067159021 10671590 Drug administration error
1067159021 10671590 Drug dose omission
1067159021 10671590 Drug intolerance
1067159021 10671590 Dyspnoea
1067159021 10671590 Emergency care
1067159021 10671590 Erythema
1067159021 10671590 Feeling hot
1067159021 10671590 Flushing
1067159021 10671590 Headache
1067159021 10671590 Hospitalisation
1067159021 10671590 Malaise
1067159021 10671590 Nausea
1067159021 10671590 Neuropathy peripheral
1067159021 10671590 Ocular discomfort
1067159021 10671590 Pain in extremity
1067159021 10671590 Pain in jaw
1067159021 10671590 Palpitations
1067159021 10671590 Pneumonia
1067159021 10671590 Rash generalised
1067159021 10671590 Restless legs syndrome
1067159021 10671590 Upper respiratory tract infection
1067159021 10671590 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1067159021 10671590 1 20141209 0
1067159021 10671590 3 20141209 0
1067159021 10671590 4 20141209 0
1067159021 10671590 6 20141214 0
1067159021 10671590 7 20141212 0
1067159021 10671590 9 20141212 0
1067159021 10671590 12 20141212 0